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Introduction
Systemic type of juvenile idiopathic arthritis (JIA) is
highly active autoimmune process. One of its severe
complications is macrophage activation syndrome, ser-
iously influenced the outcome of the disease. The aim
of the report is to reveal the macrophage activation syn-
drome during the onset of JIA, before treatment.
Objectives
A patient 1.3 years old, in the onset of JIA.
Methods
All routine analyses, including the blood test, biochemical
serum determination of antinuclear antibodies to autoim-
mune hepatitis, markers of viral hepatitis, anitbodies to
Epstein-Barr virus, CMV, herpes infection, toxoplasmosis,
chlamydia, mycoplasmosis, HIV were performed. Instru-
mental methods included: chest radiography, tomography
t, echocardiography, electrocardiography.
Results
History of the disease: the beginning of the disease was
characterized with erythematosis rash and febrile tem-
perature. Infectious diseases were excluded. Therapy
with 10 mg of prednisolone per day had a temporary
positive effect. However, varicella relapse with recurrent
fever took place 3 weeks after.
The following symptoms have been reported: fever up to
39.00C, a rash on the upper limbs, thighs, legs, swelling of
the knee joints, morning stiffness, vasculitis in the form of
erythematous spots all over the body, carditis, pneumonitis,
enterocolitis , lymphadenopathy . In blood – leukocytosis -
28.2 thousand with a shift to young leukocyte cells, eritro-
cyte sedimentation - 48 mm/h ; CRP - 78.2mg, rheumatoid
factor, antinuclear antibodies - negative, normal range of
ferritine. High dose methylprednisolone therapy – not
effective. Deterioration due to bronchopulmonary infec-
tion. Chest radiography and tomography revealed bronch-
iolitis, bronhoobstructive syndrome and respiratory
insufficiency. Immunosuppressive therapy combined with
antibiotic therapy, after which autoimmune hepatitis (ALT
- 4898 IU/l, AST -3100 IU/l, ferritin – 3600 mkg/l , LDH
-1200 IU /l, Bil total - 116 mmol/l .However,clinicall situa-
tion became much better: normal body temperature, relief
of rashes and respiratory failure. Leicocytosis decreased to
17x103. Macrophage activation syndrome was possible,
but there was no decrease of platelets. Therapy included
2 mg/kg of prednisolone orally, detoxication, hepatopro-
tectors therapy, correction of hemostasis. Within 3 weeks
there was a slow decline in level of transaminases, ferritin,
total bilirubin what gave opportunity to reduce doze to
1,3 mg/day.
Conclusion
Analyze of the disease symptoms showed that the autoim-
mune hepatitis had been developed because of the macro-
phage activation syndrome after using the antibacterial
drug. Probably, such pathology reaction of the immune
system is genetically determined. It was unexpectedly, that
oral usage of prednisolone would show better efficiency in
compare with pulse therapy. Our case illustrates the diffi-
culty of MAS diagnostics in children with JIA and can be
the result of immune system hyperactivity caused by
unknown reasons. Mechanisms of MAS syndrome require
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